These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21520178)
21. Cyclin Y binds and activates CDK4 to promote the G1/S phase transition in hepatocellular carcinoma cells via Rb signaling. Chen L; Wang X; Cheng H; Zhang W; Liu Y; Zeng W; Yu L; Huang C; Liu G Biochem Biophys Res Commun; 2020 Dec; 533(4):1162-1169. PubMed ID: 33039146 [TBL] [Abstract][Full Text] [Related]
23. Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. Baek HJ; Lee YM; Kim TH; Kim JY; Park EJ; Iwabuchi K; Mishra L; Kim SS Int J Biol Sci; 2016; 12(2):172-83. PubMed ID: 26884715 [TBL] [Abstract][Full Text] [Related]
24. TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF. Kim SS; Shetty K; Katuri V; Kitisin K; Baek HJ; Tang Y; Marshall B; Johnson L; Mishra B; Mishra L Biochem Biophys Res Commun; 2006 Jun; 344(4):1216-23. PubMed ID: 16650383 [TBL] [Abstract][Full Text] [Related]
25. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells. Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364 [TBL] [Abstract][Full Text] [Related]
26. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Warner BJ; Blain SW; Seoane J; Massagué J Mol Cell Biol; 1999 Sep; 19(9):5913-22. PubMed ID: 10454538 [TBL] [Abstract][Full Text] [Related]
27. Loss of the transforming growth factor-β effector β2-Spectrin promotes genomic instability. Chen J; Shukla V; Farci P; Andricovich J; Jogunoori W; Kwong LN; Katz LH; Shetty K; Rashid A; Su X; White J; Li L; Wang AY; Blechacz B; Raju GS; Davila M; Nguyen BN; Stroehlein JR; Chen J; Kim SS; Levin H; Machida K; Tsukamoto H; Michaely P; Tzatsos A; Mishra B; Amdur R; Mishra L Hepatology; 2017 Feb; 65(2):678-693. PubMed ID: 28114741 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472 [TBL] [Abstract][Full Text] [Related]
29. Epigenetic silencing of beta-spectrin, a TGF-beta signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome. Yao ZX; Jogunoori W; Choufani S; Rashid A; Blake T; Yao W; Kreishman P; Amin R; Sidawy AA; Evans SR; Finegold M; Reddy EP; Mishra B; Weksberg R; Kumar R; Mishra L J Biol Chem; 2010 Nov; 285(46):36112-20. PubMed ID: 20739274 [TBL] [Abstract][Full Text] [Related]
30. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907 [TBL] [Abstract][Full Text] [Related]
31. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma. Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552 [TBL] [Abstract][Full Text] [Related]
32. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Ando K; Griffin JD Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452 [TBL] [Abstract][Full Text] [Related]
33. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Reynisdóttir I; Polyak K; Iavarone A; Massagué J Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471 [TBL] [Abstract][Full Text] [Related]
34. Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway. Wang J; Yang T; Chen H; Li H; Zheng S Biochem Biophys Res Commun; 2018 Apr; 498(3):424-430. PubMed ID: 29477843 [TBL] [Abstract][Full Text] [Related]
35. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Herrera RE; Mäkelä TP; Weinberg RA Mol Biol Cell; 1996 Sep; 7(9):1335-42. PubMed ID: 8885230 [TBL] [Abstract][Full Text] [Related]
36. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4. Wan J; Liu H; Yang L; Ma L; Liu J; Ming L Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344 [TBL] [Abstract][Full Text] [Related]
38. microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma. Lu Z; Li X; Xu Y; Chen M; Chen W; Chen T; Tang Q; He Z Cell Death Dis; 2019 Sep; 10(10):723. PubMed ID: 31558704 [TBL] [Abstract][Full Text] [Related]
39. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma. Murata M; Yoshida K; Yamaguchi T; Matsuzaki K World J Gastroenterol; 2014 Nov; 20(41):15018-27. PubMed ID: 25386050 [TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. Rich JN; Zhang M; Datto MB; Bigner DD; Wang XF J Biol Chem; 1999 Dec; 274(49):35053-8. PubMed ID: 10574984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]